158 related articles for article (PubMed ID: 22623216)
1. Treatment and survival of osseous renal cell carcinoma metastases.
Evenski A; Ramasunder S; Fox W; Mounasamy V; Temple HT
J Surg Oncol; 2012 Dec; 106(7):850-5. PubMed ID: 22623216
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osseous metastases in patients with renal cell carcinoma.
Jung ST; Ghert MA; Harrelson JM; Scully SP
Clin Orthop Relat Res; 2003 Apr; (409):223-31. PubMed ID: 12671506
[TBL] [Abstract][Full Text] [Related]
3. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.
Althausen P; Althausen A; Jennings LC; Mankin HJ
Cancer; 1997 Sep; 80(6):1103-9. PubMed ID: 9305711
[TBL] [Abstract][Full Text] [Related]
5. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
6. Survival after complete surgical resection of multiple metastases from renal cell carcinoma.
Alt AL; Boorjian SA; Lohse CM; Costello BA; Leibovich BC; Blute ML
Cancer; 2011 Jul; 117(13):2873-82. PubMed ID: 21692048
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of osseous metastases in patients with renal cell carcinoma.
Dürr HR; Maier M; Pfahler M; Baur A; Refior HJ
Clin Orthop Relat Res; 1999 Oct; (367):283-90. PubMed ID: 10546626
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
[TBL] [Abstract][Full Text] [Related]
9. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
10. Pattern of metastases in renal cell carcinoma: a single institution study.
Sivaramakrishna B; Gupta NP; Wadhwa P; Hemal AK; Dogra PN; Seth A; Aron M; Kumar R
Indian J Cancer; 2005; 42(4):173-7. PubMed ID: 16391434
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
Mani S; Todd MB; Katz K; Poo WJ
J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone.
Toyoda Y; Shinohara N; Harabayashi T; Abe T; Akino T; Sazawa A; Nonomura K
Eur Urol; 2007 Jul; 52(1):163-8. PubMed ID: 17098353
[TBL] [Abstract][Full Text] [Related]
15. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
16. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of bone metastases from renal cell carcinoma].
Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
[TBL] [Abstract][Full Text] [Related]
18. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
[TBL] [Abstract][Full Text] [Related]
19. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
20. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]